Previous 10 | Next 10 |
Shares of the recombinant-protein vaccine specialist Novavax (NASDAQ: NVAX) were down by a noteworthy 9.2% on heavy volume as of 9:55 a.m. ET on Thursday. As a result, the biotech's stock price hit a fresh 52-week low this morning. What's weighing on Novavax's shares today? ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Tada Images/ShutterStock.com Accenture (NYSE: ACN ) stock is on the move Thursday after releasing earnings and announcing an acquisition. Starting with earnings, the company reported diluted earnings ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Willy Barton / Shutterstock.com Spero Therapeutics (NASDAQ: SPRO ) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (NYSE: GSK ). This deal covers the...
Novavax ( NASDAQ: NVAX ) shares dropped ~6% in the pre-market trading Thursday after JPMorgan downgraded the Maryland-based COVID-19 vaccine maker to Underweight from Neutral, citing, among other things, the company’s long-term outlook. In addition to an updated m...
As a company, if the need for your latest and highest-profile product is declining rapidly, some investors are likely to bail. That dynamic was very much in force with Novavax (NASDAQ: NVAX) stock on Monday, and to a lesser extent with its healthcare industry peer Johnson &...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s a mixed day for the stock market, but it’s not a good day for vaccine stocks. Across the board, these names are getting sold. Pfizer (NYSE: PFE ) is down 2%, while Moderna (NASDAQ: MRNA ) is...
Novavax ( NASDAQ: NVAX ) announced Friday that the Israel Ministry of Health greenlighted the use of its COVID-19 vaccine Nuvaxovid in those aged 12 years and above for immunization against coronavirus disease. The import and use permit issued by the ministry allows the us...
Novavax Nuvaxovid™ COVID-19 Vaccine Receives Expanded Emergency Use Authorization in Taiwan for Use in Adolescents Aged 12 Through 17 PR Newswire GAITHERSBURG, Md. , Sept. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology ...
Novavax Nuvaxovid™ COVID-19 Vaccine Now Available in Israel for Individuals Aged 12 and Older PR Newswire The Israeli Advisory Committee on Epidemics has recommended that Nuvaxovid™ be approved for ages 12 and older as a primary series and as a heterolo...
Novavax, Inc. (NVAX) Baird 2022 Global Healthcare Conference Call September 13, 2022 08:30 ET Company Participants Gregory Glenn - President, R&D John Trizzino - Chief Commercial Officer and Chief Business Officer Presentation Unidentified Analyst ...
News, Short Squeeze, Breakout and More Instantly...
Highlights Novavax’s Massive Untapped Value That it Believes is Being Hindered by an Overly Conservative Board and Management That Clings to Failed Strategies and Have Undermined Stockholder Value Calls for Fresh Perspectives in the Boardroom to Restore Investor Confidence in the...
2024-04-29 08:10:00 ET The market isn't rational always and everywhere. Sometimes, shares of excellent companies with bright futures almost inexplicably fail to keep pace with broader equities. When that happens, it's worth it to buy the dip. Other times, some corporations lag the market fo...
Believes the two new nominated directors possess the necessary experience to tackle the underperformance of the business which will improve its sh...